Goot Heah Khor

Goot Heah Khor

Auto-generated profile, based on publicly available information

Goot Heah Khor

Centre for Preclinical Science Studies, Faculty of Dentistry Universiti Teknologi MARA, SG. Buloh Campus Sungai Buloh Selangor Malaysia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in International Journal of Medical Sciences
Verified
Journal Article
Open access
GKGoot Heah Khor
Goot Heah Khor
Gabriele FroemmingGabriele Froemming
Gabriele Froemming
RZRosnah Binti Zain
Rosnah Binti Zain
MAMannil Thomas Abraham
Mannil Thomas Abraham
EOEffat Omar
Effat Omar
KTKwai Lin Thong
Kwai Lin Thong
Hypermethylation in promoter regions of genes might lead to altered gene functions and result in malignant cellular transformation. Thus, biomarker identification for hypermethylated genes would be very useful for early diagnosis, prognosis, and therapeutic treatment of oral squamous cell carcinoma (OSCC). The objectives of this study were to screen and validate differentially hypermethylated genes in OSCC and correlate the hypermethylation-induced genes with demographic, clinocopathological characteristics and survival rate of OSCC. DNA methylation profiling was utilized to screen the differentially hypermethylated genes in OSCC. Three selected differentially-hypermethylated genes of p16, DDAH2 and DUSP1 were further validated for methylation status and protein expression. The correlation between demographic, clinicopathological characteristics, and survival rate of OSCC patients with hypermethylation of p16, DDAH2 and DUSP1 genes were analysed in the study. Methylation profiling demonstrated 33 promoter hypermethylated genes in OSCC. The differentially-hypermethylated genes of p16, DDAH2 and DUSP1 revealed positivity of 78%, 80% and 88% in methylation-specific polymerase chain reaction and 24% and 22% of immunoreactivity in DDAH2 and DUSP1 genes, respectively. Promoter hypermethylation of p16 gene was found significantly associated with tumour site of buccal, gum, tongue and lip (P=0.001). In addition, DDAH2 methylation level was correlated significantly with patients' age (P=0.050). In this study, overall five-year survival rate was 38.1% for OSCC patients and was influenced by sex difference. The study has identified 33 promoter hypermethylated genes that were significantly silenced in OSCC, which might be involved in an important mechanism in oral carcinogenesis. Our approaches revealed signature candidates of differentially hypermethylated genes of DDAH2 and DUSP1 which can be further developed as potential biomarkers for OSCC as diagnostic, prognostic and therapeutic targets in the future.

6 November 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
GKGoot Heah Khor
Goot Heah Khor
Gabriele FroemmingGabriele Froemming
Gabriele Froemming
RZRosnah Binti Zain
Rosnah Binti Zain
MAMannil Thomas Abraham
Mannil Thomas Abraham
KTKwai Lin Thong
Kwai Lin Thong
Screening of Differential Promoter Hypermethylated Genes in Primary Oral Squamous Cell Carcinoma Microarray;oral squamous cell carcinoma;promoter hypermethylation;MSPCR; Background: Promoter hypermethylation leads to altered gene functions and may result in malignant cellular transformation. Thus, identification of biomarkers for hypermethylated genes could be useful for diagnosis, prognosis, and therapeutic treatment of oral squamous cell carcinoma (OSCC). Objectives: To screen hypermethylated genes with a microarray approach and to validate selected hypermethylated genes with the methylation-specific polymerase chain reaction (MSPCR). Materials and Methods: Genome-wide analysis of normal oral mucosa and OSCC tissues was conducted using the Illumina methylation microarray. The specified differential genes were selected and hypermethylation status was further verified with an independent cohort sample of OSCC samples. Candidate genes were screened using microarray assay and run by MSPCR analysis. Results: TP73, PIK3R5, and CELSR3 demonstrated high percentages of differential hypermethylation status. Conclusions: Our microarray screening and MSPCR approaches revealed that the signature candidates of differentially hypermethylated genes may possibly become potential biomarkers which would be useful for diagnostic, prognostic and therapeutic targets of OSCC in the near future.

31 December 2012 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
KGKhor Goot-Heah
Khor Goot-Heah
TKThong Kwai-Lin
Thong Kwai-Lin
Gabriele FroemmingGabriele Froemming
Gabriele Froemming
MAMannil Thomas Abraham
Mannil Thomas Abraham
NRNik Mohd Mazuan Nik Nik Mohd Rosdy
Nik Mohd Mazuan Nik Nik Mohd Rosdy
RZRosnah Binti Zain
Rosnah Binti Zain
Oral cancer has become one of the most prevalent cancers worldwide and human Papillomavirus is one of the risk factors for developing oral cancer. For this study HPV18 was chosen as it is one of the high risk HPV types and may lead to carcinogenesis. However, prevalence of HPV18 infection in Oral Squamous Cell Carcinoma in Malaysia remains unclear. This study aimed to investigate the viral load of HPV18 DNA in OSCC and potentially malignant lesions using saliva samples. Genomic DNAs of thirty saliva samples of normal subjects and thirty saliva samples compromised of 16 samples from potentially malignant lesions and 14 of OSCC patients were amplified for HPV18 DNA using a nested polymerase chain reaction analysis. All PCR products were then analyzed using the Bioanalyzer to confirm presence of HPV18 DNA. From thirty patients examined, only one of 30 (3.3%) cases was found to be positive for HPV18 in this study. The finding of this study revealed that there is a low viral detection of HPV18 in Malaysian OSCC by using saliva samples, suggesting that prevalence of HPV18 may not be important in this group of Malaysian OSCC.

5 February 2016 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
GKGoot Heah Khor
Goot Heah Khor
Gabriele FroemmingGabriele Froemming
Gabriele Froemming
RZRosnah Binti Zain
Rosnah Binti Zain
TAThomas Mannil Abraham
Thomas Mannil Abraham
TLThong Kwai Lin
Thong Kwai Lin
Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma CELSR3;hypermethylation;oral squamous cell carcinoma;biomarker; Background: Promoter hypermethylation is a frequent epigenetic mechanism for gene transcription repression in cancer and is one of the hallmarks of the disease. Cadherin EGF LAG seven-pass G-type receptor 3 (CELSR3) contributes to cell contact-mediated communication. Dysregulation of promoter methylation has been reported in various cancers. Objectives: The objectives of this study were to investigate the CELSR3 hypermethylation level in oral squamous cell carcinomas (OSCCs) using methylation-sensitive high-resolution melting analysis (MS-HRM) and to correlate CELSR3 methylation with patient demographic and clinicopathological parameters. Materials and Methods: Frozen tissue samples of healthy subjects' normal mucosa and OSCCs were examined with regard to their methylation levels of the CELSR3 gene using MS-HRM. Results: MS-HRM analysis revealed a high methylation level of CELSR3 in 86% of OSCC cases. Significant correlations were found between CELSR3 quantitative methylation levels with patient ethnicity (P=0.005), age (P=0.024) and pathological stages (P=0.004). A moderate positive correlation between CELSR3 and patient age was also evident (R=0.444, P=0.001). Conclusions: CELSR3 promoter hypermethylation may be an important mechanism involved in oral carcinogenesis. It may thus be used as a biomarker in OSCC prognostication.

1 January 2011
Verified
Journal Article
Closed access
KHKhor Goot Heah
Khor Goot Heah
MHMohamed Ibrahim Abu Hassan
Mohamed Ibrahim Abu Hassan
SHSiar Chong Huat
Siar Chong Huat

1 August 2021 in Jurnal Teknologi (Sciences & Engineering)
Verified
Journal Article
Closed access
PDF file
NRNur Batrisyia Ruslan
Nur Batrisyia Ruslan
DADr. Indah Mohd binti mohd Amin
Dr. Indah Mohd binti mohd Amin
NHNarimah Abdul Hamid Hasani
Narimah Abdul Hamid Hasani
VAVivi Noryati Ahmad
Vivi Noryati Ahmad
FAFarizan Aris
Farizan Aris
GKGoot Heah Khor
Goot Heah Khor
Dillapiole is one of the major compounds in Peperomia pellucida. Dillapiole exerts cytotoxicity effect on several cancer cells such as breast and colon with a minimal effect on normal cells. However, its effect on cancers in head and neck region remains ambiguous. Therefore, in the current study, the cytotoxicity effect of dillapiole on human nasal squamous cell carcinoma, RPMI 2650 and the underlying mechanism were investigated. Normal human gingival fibroblast, HGnF cells was used as comparison. Cisplatin and untreated cells were used as positive and negative controls, respectively. Cell cytotoxicity was determined using WST-1 assay; and validated by trypan blue exclusion assays. Cell death mechanism was determined using Annexin V-FITC detection kit and analyzed by flow cytometer. The cytotoxic effect of dillapiole on RPMI 2650 cells was shown significantly increased with the increasing amount of dillapiole from 25.93 ± 6.39 % to 83.87 ± 8.43 % (p<0.05, n=3) with the respective IC50 and IC75 of 46 µM and 125 µM. None of both IC50 and IC75 were obtained for HGnF cells up to 150 µM. Loss of normal shape, cytoplasm shrinkage and reduction in cell volume were detected in RPMI 2650 cells after dillapiole treatment at respective IC50 (46 µM) and IC75 (125 µM), indicating apoptosis. These findings indicate that dillapiole cytotoxicity effect is more selective towards RPMI 2650 compared to HGnF cells and the mechanism of death was through the induction of apoptosis.